
Mark Hellner
Examiner (ID: 18378, Phone: (571)272-6981 , Office: P/3645 )
| Most Active Art Unit | 3645 |
| Art Unit(s) | 2202, 3662, 3645, 3648, 3642, 3663 |
| Total Applications | 4184 |
| Issued Applications | 3711 |
| Pending Applications | 223 |
| Abandoned Applications | 288 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5125555
[patent_doc_number] => 20070237826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Polymerized solid lipid nanoparticles for oral or mucosal delivery of therapeutic proteins and peptides'
[patent_app_type] => utility
[patent_app_number] => 11/397963
[patent_app_country] => US
[patent_app_date] => 2006-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5560
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20070237826.pdf
[firstpage_image] =>[orig_patent_app_number] => 11397963
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/397963 | Polymerized solid lipid nanoparticles for oral or mucosal delivery of therapeutic proteins and peptides | Apr 4, 2006 | Abandoned |
Array
(
[id] => 5851087
[patent_doc_number] => 20060234278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Sequences used to identify if a female mammal comprises a mutation in the alpha-fetoprotein sequence(S) or a partial or total deletion of the alpha-fetoprotein sequence(S)'
[patent_app_type] => utility
[patent_app_number] => 11/397356
[patent_app_country] => US
[patent_app_date] => 2006-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9855
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234278.pdf
[firstpage_image] =>[orig_patent_app_number] => 11397356
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/397356 | Sequences used to identify if a female mammal comprises a mutation in the alpha-fetoprotein sequence(S) or a partial or total deletion of the alpha-fetoprotein sequence(S) | Apr 2, 2006 | Abandoned |
Array
(
[id] => 5473009
[patent_doc_number] => 20090246175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'THERAPEUTIC USE OF SCIN, A STAPHYLOCOCCAL COMPLEMENT INHIBITOR IN INFLAMMATORY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 11/909915
[patent_app_country] => US
[patent_app_date] => 2006-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13855
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246175.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909915
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909915 | THERAPEUTIC USE OF SCIN, A STAPHYLOCOCCAL COMPLEMENT INHIBITOR IN INFLAMMATORY DISEASES | Apr 2, 2006 | Abandoned |
Array
(
[id] => 5403549
[patent_doc_number] => 20090238863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'LIPOSOME COMPOSITION FOR INDUCTION OF IMMUNITY'
[patent_app_type] => utility
[patent_app_number] => 11/909912
[patent_app_country] => US
[patent_app_date] => 2006-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6881
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20090238863.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909912
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909912 | LIPOSOME COMPOSITION FOR INDUCTION OF IMMUNITY | Mar 28, 2006 | Abandoned |
Array
(
[id] => 5632239
[patent_doc_number] => 20060148709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Neuroprotective properties of GDF-15, a novel member of the TGF-Beta superfamily'
[patent_app_type] => utility
[patent_app_number] => 11/372281
[patent_app_country] => US
[patent_app_date] => 2006-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5581
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148709.pdf
[firstpage_image] =>[orig_patent_app_number] => 11372281
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/372281 | Neuroprotective properties of GDF-15, a novel member of the TGF-Beta superfamily | Mar 8, 2006 | Abandoned |
Array
(
[id] => 5643225
[patent_doc_number] => 20060281680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Methods and compositions for modulating vascular integrity'
[patent_app_type] => utility
[patent_app_number] => 11/371631
[patent_app_country] => US
[patent_app_date] => 2006-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 30917
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20060281680.pdf
[firstpage_image] =>[orig_patent_app_number] => 11371631
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/371631 | Methods and compositions for modulating vascular integrity | Mar 8, 2006 | Abandoned |
Array
(
[id] => 5354744
[patent_doc_number] => 20090186088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'INHALABLE DRUG'
[patent_app_type] => utility
[patent_app_number] => 11/908757
[patent_app_country] => US
[patent_app_date] => 2006-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 14487
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20090186088.pdf
[firstpage_image] =>[orig_patent_app_number] => 11908757
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908757 | INHALABLE DRUG | Mar 7, 2006 | Abandoned |
Array
(
[id] => 5732266
[patent_doc_number] => 20060257383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Human skin equivalents expressing exogenous polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/365357
[patent_app_country] => US
[patent_app_date] => 2006-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 23769
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257383.pdf
[firstpage_image] =>[orig_patent_app_number] => 11365357
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/365357 | Human skin equivalents expressing exogenous polypeptides | Feb 28, 2006 | Issued |
Array
(
[id] => 5732348
[patent_doc_number] => 20060257465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Methods for preparation of lipid-encapsulated therapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 11/359999
[patent_app_country] => US
[patent_app_date] => 2006-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15378
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257465.pdf
[firstpage_image] =>[orig_patent_app_number] => 11359999
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/359999 | Methods for preparation of lipid-encapsulated therapeutic agents | Feb 21, 2006 | Abandoned |
Array
(
[id] => 827064
[patent_doc_number] => 07402730
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-07-22
[patent_title] => 'Knockout animals manifesting hyperlipidemia'
[patent_app_type] => utility
[patent_app_number] => 11/347838
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24222
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/402/07402730.pdf
[firstpage_image] =>[orig_patent_app_number] => 11347838
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/347838 | Knockout animals manifesting hyperlipidemia | Feb 2, 2006 | Issued |
Array
(
[id] => 4799110
[patent_doc_number] => 20080010696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Method of Determining Gene Relating to Favorable Beef Taste and Texture'
[patent_app_type] => utility
[patent_app_number] => 11/815559
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6699
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20080010696.pdf
[firstpage_image] =>[orig_patent_app_number] => 11815559
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/815559 | Method of Determining Gene Relating to Favorable Beef Taste and Texture | Feb 2, 2006 | Abandoned |
Array
(
[id] => 5682557
[patent_doc_number] => 20060198827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'Engineering vascularized muscle tissue'
[patent_app_type] => utility
[patent_app_number] => 11/347831
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8082
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20060198827.pdf
[firstpage_image] =>[orig_patent_app_number] => 11347831
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/347831 | Engineering vascularized muscle tissue | Feb 2, 2006 | Abandoned |
Array
(
[id] => 5844368
[patent_doc_number] => 20060122142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'DNA vaccines for farm animals, in particular bovines and porcines'
[patent_app_type] => utility
[patent_app_number] => 11/343165
[patent_app_country] => US
[patent_app_date] => 2006-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19217
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122142.pdf
[firstpage_image] =>[orig_patent_app_number] => 11343165
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/343165 | DNA vaccines for farm animals, in particular bovines and porcines | Jan 29, 2006 | Abandoned |
Array
(
[id] => 5618957
[patent_doc_number] => 20060188490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Transfection of blood cells with mRNA for immune stimulation and gene therapy'
[patent_app_type] => utility
[patent_app_number] => 11/342392
[patent_app_country] => US
[patent_app_date] => 2006-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9423
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188490.pdf
[firstpage_image] =>[orig_patent_app_number] => 11342392
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/342392 | Transfection of blood cells with mRNA for immune stimulation and gene therapy | Jan 29, 2006 | Abandoned |
Array
(
[id] => 5705223
[patent_doc_number] => 20060194271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex'
[patent_app_type] => utility
[patent_app_number] => 11/341908
[patent_app_country] => US
[patent_app_date] => 2006-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15685
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194271.pdf
[firstpage_image] =>[orig_patent_app_number] => 11341908
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/341908 | Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex | Jan 26, 2006 | Issued |
Array
(
[id] => 5160427
[patent_doc_number] => 20070173471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Morphogen compositions and methods of use thereof to treat heart disorders'
[patent_app_type] => utility
[patent_app_number] => 11/339808
[patent_app_country] => US
[patent_app_date] => 2006-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 21263
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20070173471.pdf
[firstpage_image] =>[orig_patent_app_number] => 11339808
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/339808 | Morphogen compositions and methods of use thereof to treat heart disorders | Jan 23, 2006 | Abandoned |
Array
(
[id] => 5107674
[patent_doc_number] => 20070066552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 11/336664
[patent_app_country] => US
[patent_app_date] => 2006-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 53888
[patent_no_of_claims] => 179
[patent_no_of_ind_claims] => 128
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0066/20070066552.pdf
[firstpage_image] =>[orig_patent_app_number] => 11336664
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/336664 | Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids | Jan 19, 2006 | Abandoned |
Array
(
[id] => 5704792
[patent_doc_number] => 20060193840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Perivascular mesenchymal precursor cell induced blood vessel formation'
[patent_app_type] => utility
[patent_app_number] => 11/326736
[patent_app_country] => US
[patent_app_date] => 2006-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 16272
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20060193840.pdf
[firstpage_image] =>[orig_patent_app_number] => 11326736
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/326736 | Perivascular mesenchymal precursor cell induced blood vessel formation | Jan 4, 2006 | Issued |
Array
(
[id] => 5777342
[patent_doc_number] => 20060105982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Non-invasive gene targeting to ocular cells'
[patent_app_type] => utility
[patent_app_number] => 11/321009
[patent_app_country] => US
[patent_app_date] => 2005-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10796
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20060105982.pdf
[firstpage_image] =>[orig_patent_app_number] => 11321009
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/321009 | Non-invasive gene targeting to ocular cells | Dec 27, 2005 | Abandoned |
Array
(
[id] => 5022801
[patent_doc_number] => 20070148767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Method of forming multicellular spheroids from the cultured cells'
[patent_app_type] => utility
[patent_app_number] => 11/318882
[patent_app_country] => US
[patent_app_date] => 2005-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5654
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20070148767.pdf
[firstpage_image] =>[orig_patent_app_number] => 11318882
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/318882 | Method of forming multicellular spheroids from the cultured cells | Dec 27, 2005 | Abandoned |